Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.

NCT06245590 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Decompensated Cirrhosis

Interventions

DRUG: Albumin
DRUG: Midodrine
OTHER: Standard of Care

Sponsor

Institute of Liver and Biliary Sciences, India